Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker Metsera does not raise any antitrust issues.

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply ...

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply ...

India’s GLP-1 drug market is poised for explosive growth, outpacing global trends and positioning domestic pharma giants to ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

What's better than investing in a stock with a promising outlook? Investing in a beaten-down stock with a promising outlook.

Pfizer has now filed a suit in federal court, following its claim in state court on Friday. It is riding Trump-era political ...

Novo Nordisk is confident its bid for U.S. drugmaker Metsera doesn't raise antitrust issues. The $8.5 billion offer tops ...

Marc Filippino Good morning from the Financial Times. Today is Tuesday, November 4th, and this is your FT News Briefing.